Children as hematopoietic stem cell donors.

Pediatrics
American Academy of Pediatrics. Committee on Bioethics

Abstract

In the past half-century, hematopoietic stem cell transplantation has become standard treatment for a variety of diseases in children and adults, including selected hematologic malignancies, immunodeficiencies, hemoglobinopathies, bone marrow failure syndromes, and congenital metabolic disorders. There are 3 sources of allogeneic hematopoietic stem cells: bone marrow, peripheral blood, and umbilical cord blood; each has its own benefits and risks. Children often serve as hematopoietic stem cell donors, most commonly for their siblings. HLA-matched biological siblings are generally preferred as donors because of reduced risks of transplant-related complications as compared with unrelated donors. This statement includes a discussion of the ethical considerations regarding minors serving as stem cell donors, using the traditional benefit/burden calculation from the perspectives of both the donor and the recipient. The statement also includes an examination of the circumstances under which a minor may ethically participate as a hematopoietic stem cell donor, how the risks can be minimized, what the informed-consent process should entail, the role for a donor advocate (or some similar mechanism), and other ethical concerns. The Amer...Continue Reading

References

Apr 1, 1995·Journal of Medical Ethics·C Elliott
Oct 1, 1996·Behavioral Sciences & the Law·V Weisz, J K Robbennolt
Oct 1, 1997·Social Science & Medicine·N Press, C H Browner
May 14, 1998·Social Work in Health Care·W I Shama
Oct 12, 1999·Bone Marrow Transplantation·W Packman
Nov 15, 2002·Oncology Nursing Forum·Sue P HeineyJill Michaels
May 6, 2004·Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees·Rebecca D PentzMartin Korbling
Oct 20, 2004·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Wendy PackmanMary Crittenden
May 31, 2007·Psycho-oncology·Lori S WienerTerry Fry
May 6, 2009·Archives of Pediatrics & Adolescent Medicine·Jennifer C KesselheimSteven Joffe
Nov 4, 2009·Archives of Pediatrics & Adolescent Medicine·Lainie Friedman Ross
Jan 27, 2010·Pediatrics·UNKNOWN American Academy of Pediatrics. Committee on Bioethics
Mar 17, 2010·Blood·Paul V O'DonnellUNKNOWN Donor Health and Safety Working Committee from Center for International Blood and Marrow Transplant Research (CIBMTR)
Feb 8, 2011·Pediatric Blood & Cancer·Steven Joffe, Eric Kodish

❮ Previous
Next ❯

Citations

Nov 7, 2013·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Robert Noggle
Feb 23, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lainie Friedman RossUNKNOWN American College of Medical Genetics and Genomics
Sep 29, 2011·Journal of Paediatrics and Child Health·Aric Bendorf, Ian H Kerridge
Feb 3, 2011·Pediatrics in Review·Robert Macauley
Oct 29, 2011·Monash Bioethics Review·Michelle Taylor-Sands
Jan 27, 2010·Pediatrics·UNKNOWN American Academy of Pediatrics. Committee on Bioethics
Dec 25, 2015·Pediatric Blood & Cancer·Cynthia A GerhardtMelissa A Alderfer
Oct 6, 2012·Pediatric Clinics of North America·Naomi LaventhalJohn Lantos
Aug 27, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Menachem BitanMichael A Pulsipher
Nov 21, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bambi J Grilley
Feb 8, 2011·Pediatric Blood & Cancer·Steven Joffe, Eric Kodish
Jun 28, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Musa Karakukcu, Ekrem Unal
Jan 27, 2016·Journal of Adolescent and Young Adult Oncology·Meaghann S WeaverBrandon Triplett
Feb 3, 2015·Pediatric Blood & Cancer·Wendy PelletierGregory M T Guilcher
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Naynesh KamaniJeffrey P Kahn
May 15, 2015·The American Journal of Bioethics : AJOB·Liza-Marie JohnsonJustin N Baker
Jan 13, 2015·Journal of Pediatric Nursing·Jennifer P D'AuriaKimberly A Kasow
Mar 24, 2012·Blood·Michael A Pulsipher
Jun 19, 2010·Blood·Bronwen E Shaw
Oct 21, 2014·Bone Marrow Transplantation·N N ShahD Wendler
Oct 30, 2016·The Journal of Pediatrics·Galen E SwitzerMichael A Pulsipher
Jun 27, 2017·Bone Marrow Transplantation·G E SwitzerM A Pulsipher
Apr 13, 2018·Western Journal of Nursing Research·Kristin StegengaPamela S Hinds
Dec 16, 2017·Pediatric Research·Naomi T LaventhalValerie P Opipari
May 1, 2018·Transplantation·David SchenckLainie Friedman Ross
Feb 26, 2016·Clinical Trials : Journal of the Society for Clinical Trials·David WendlerChristine Grady
Mar 23, 2017·Case Reports in Hematology·Andrea Z PereiraMarco Aurélio Scarpinella Bueno
Aug 17, 2019·European Journal of Haematology·Giovanni Rubeis, Florian Steger
Apr 12, 2019·Bone Marrow Transplantation·Elad Jacoby, Daphna Hutt
Jun 11, 2015·Journal of Paediatrics and Child Health·Shih-Ning Then
May 3, 2018·The Medical Journal of Australia·Shih-Ning ThenMichael Marks
Jan 4, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael A PulsipherGalen E Switzer
May 11, 2021·Asian Bioethics Review·Chee Ying KuekPek San Tay
Mar 18, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Leslie Lehmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.